Jonathan Wolleben
Stock Analyst at JMP Securities
(4.23)
# 477
Out of 4,711 analysts
177
Total ratings
50.29%
Success rate
14.94%
Average return
Main Sectors:
Stocks Rated by Jonathan Wolleben
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SVRA Savara | Reiterates: Market Outperform | $9 | $3.23 | +178.64% | 8 | Dec 19, 2024 | |
| HGV Hilton Grand Vacations | Maintains: Market Outperform | $55 → $50 | $39.30 | +27.23% | 1 | Dec 18, 2024 | |
| GPCR Structure Therapeutics | Reiterates: Market Outperform | $91 | $27.90 | +226.16% | 7 | Dec 18, 2024 | |
| CSGP CoStar Group | Reiterates: Market Outperform | $90 | $71.44 | +25.98% | 1 | Dec 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Reiterates: Market Outperform | $87 | $53.60 | +62.31% | 13 | Dec 16, 2024 | |
| ABNB Airbnb | Reiterates: Market Perform | n/a | $134.21 | - | 1 | Dec 16, 2024 | |
| PRQR ProQR Therapeutics | Reiterates: Market Outperform | $8 | $2.63 | +204.18% | 7 | Dec 12, 2024 | |
| SPRB Spruce Biosciences | Downgrades: Market Perform | $3 | $0.40 | +650.00% | 7 | Dec 11, 2024 | |
| DBVT DBV Technologies | Reiterates: Market Outperform | $10 | $3.19 | +213.48% | 11 | Dec 10, 2024 | |
| SPOT Spotify Technology | Downgrades: Accumulate | $420 → $485 | $460.88 | +5.23% | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $3 | $1.20 | +150.00% | 6 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $64 | $56.12 | +14.04% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $19 → $23 | $8.20 | +180.49% | 6 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $15 | $2.70 | +455.56% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $48 → $32 | $4.95 | +546.46% | 8 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $45 → $43 | $41.49 | +3.64% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $15 → $16 | $7.57 | +111.36% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $381 → $385 | $308.44 | +24.82% | 10 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $66 → $68 | $41.51 | +63.82% | 8 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $25 | $4.01 | +523.44% | 11 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $25 → $24 | $8.25 | +190.91% | 10 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $24 → $22 | $8.50 | +158.82% | 16 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $8 | $0.95 | +742.11% | 11 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $49 → $50 | $19.57 | +155.49% | 9 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $5 | $0.87 | +473.20% | 9 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $24 | $31.16 | -22.98% | 1 | May 12, 2023 |
Savara
Dec 19, 2024
Reiterates: Market Outperform
Price Target: $9
Current: $3.23
Upside: +178.64%
Hilton Grand Vacations
Dec 18, 2024
Maintains: Market Outperform
Price Target: $55 → $50
Current: $39.30
Upside: +27.23%
Structure Therapeutics
Dec 18, 2024
Reiterates: Market Outperform
Price Target: $91
Current: $27.90
Upside: +226.16%
CoStar Group
Dec 16, 2024
Reiterates: Market Outperform
Price Target: $90
Current: $71.44
Upside: +25.98%
Crinetics Pharmaceuticals
Dec 16, 2024
Reiterates: Market Outperform
Price Target: $87
Current: $53.60
Upside: +62.31%
Airbnb
Dec 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $134.21
Upside: -
ProQR Therapeutics
Dec 12, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $2.63
Upside: +204.18%
Spruce Biosciences
Dec 11, 2024
Downgrades: Market Perform
Price Target: $3
Current: $0.40
Upside: +650.00%
DBV Technologies
Dec 10, 2024
Reiterates: Market Outperform
Price Target: $10
Current: $3.19
Upside: +213.48%
Spotify Technology
Nov 13, 2024
Downgrades: Accumulate
Price Target: $420 → $485
Current: $460.88
Upside: +5.23%
Sep 26, 2024
Reiterates: Market Outperform
Price Target: $3
Current: $1.20
Upside: +150.00%
Sep 17, 2024
Initiates: Market Outperform
Price Target: $64
Current: $56.12
Upside: +14.04%
Sep 13, 2024
Maintains: Market Outperform
Price Target: $19 → $23
Current: $8.20
Upside: +180.49%
Sep 10, 2024
Initiates: Market Outperform
Price Target: $15
Current: $2.70
Upside: +455.56%
Aug 15, 2024
Maintains: Market Outperform
Price Target: $48 → $32
Current: $4.95
Upside: +546.46%
Aug 7, 2024
Maintains: Market Outperform
Price Target: $45 → $43
Current: $41.49
Upside: +3.64%
Aug 6, 2024
Maintains: Market Outperform
Price Target: $15 → $16
Current: $7.57
Upside: +111.36%
Jul 16, 2024
Maintains: Market Outperform
Price Target: $381 → $385
Current: $308.44
Upside: +24.82%
Jun 18, 2024
Maintains: Market Outperform
Price Target: $66 → $68
Current: $41.51
Upside: +63.82%
May 31, 2024
Reiterates: Market Outperform
Price Target: $25
Current: $4.01
Upside: +523.44%
May 10, 2024
Maintains: Market Outperform
Price Target: $25 → $24
Current: $8.25
Upside: +190.91%
May 8, 2024
Maintains: Market Outperform
Price Target: $24 → $22
Current: $8.50
Upside: +158.82%
Apr 19, 2024
Reiterates: Market Outperform
Price Target: $8
Current: $0.95
Upside: +742.11%
Apr 11, 2024
Maintains: Market Outperform
Price Target: $49 → $50
Current: $19.57
Upside: +155.49%
Mar 13, 2024
Reiterates: Market Outperform
Price Target: $5
Current: $0.87
Upside: +473.20%
May 12, 2023
Maintains: Outperform
Price Target: $25 → $24
Current: $31.16
Upside: -22.98%